Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Albuferon albumin-interferon alpha: Completed Phase III enrollment

In August, HGSI completed enrollment of 1,331 patients in the open-label,

Read the full 112 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE